General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Boehringer Ingelheim Pharmaceuticals, Inc(MODEST), Bayer Healthcare Pharmaceuticals(MODEST), Daiichi Sankyo(SIGNIFICANT), fees for lecturing on apixaban from Bristol Myers-Squibb and Pfizer, and has been an investigator in the ARISTOTLE trial (MODEST), Eli Lilly and Company(MODEST), Novartis Corporation(MODEST) RESEARCH/RESEARCH GRANTS: Roche (MODEST)

View Full Disclosure